Clinical Trial

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Name: Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma — clinical trial record (NCT07243691)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Study on the therapeutic effect of different infusion times on tislelizumab in high-risk postoperative hepatocellular carcinoma

Trial Details

NCT Number	NCT07243691
Lead Sponsor	Sir Run Run Shaw Hospital
Conditions	Hepatocellular Carcinoma
Enrollment	33 participants
Start Date	2025-12-01
Primary Completion	2027-11-01 (estimated)
Study Completion	2027-12-15 (estimated)
Updated on ClinicalTrials.gov	2025-11-24